Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33 Positive Acute Myeloid Leukemia: Results from a French Retrospective Observational Study
Blood, 2023-11, Vol.142 (Supplement 1), p.2893-2893 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-179575
Full text available